New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
How do metastatic tumor cells grow in lymph nodes?

How do metastatic tumor cells grow in lymph nodes?

by Institute for Basic Science(Left) Schematic diagram for the mechanism of tumor lymph node metastasis.(Right) (A) Stepwise growing metastatic melanoma in tumor-draining lymph node and (B) fatty
Oncology April 01,2024
How do metastatic tumor cells grow in lymph nodes?

How do metastatic tumor cells grow in lymph nodes?

by Institute for Basic Science(Left) Schematic diagram for the mechanism of tumor lymph node metastasis.(Right) (A) Stepwise growing metastatic melanoma in tumor-draining lymph node and (B) fatty
Oncology April 01,2024
Genetically modified virus shown able to kill tumors in mice with retinoblastoma

Genetically modified virus shown able to kill tumors in mice with retinoblastoma

by Bob Yirka , Medical XpressThe virus-based anticancer therapy (VCN-01) showed toxic effects against retinoblastoma cells after 12 days. Credit: G. Pascual-Pasto et al.,Science Translational Me
Oncology April 01,2024
Genetically modified virus shown able to kill tumors in mice with retinoblastoma

Genetically modified virus shown able to kill tumors in mice with retinoblastoma

by Bob Yirka , Medical XpressThe virus-based anticancer therapy (VCN-01) showed toxic effects against retinoblastoma cells after 12 days. Credit: G. Pascual-Pasto et al.,Science Translational Me
Oncology April 01,2024
Tracking down microRNA candidates that can contribute to disease

Tracking down microRNA candidates that can contribute to disease

by Ana María Rodríguez, Ph.d.,Baylor College of MedicineMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaWhat started as Ninad Oak's side project t
Oncology April 01,2024
Tracking down microRNA candidates that can contribute to disease

Tracking down microRNA candidates that can contribute to disease

by Ana María Rodríguez, Ph.d.,Baylor College of MedicineMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaWhat started as Ninad Oak's side project t
Oncology April 01,2024
Targeted hope for metastatic cancer

Targeted hope for metastatic cancer

by Paul Mayne,University of Western OntarioCancer cell during cell division. Credit: National Institutes of HealthA cancer diagnosis is tough enough to hear, but a diagnosis that cancer has spre
Oncology April 01,2024
Targeted hope for metastatic cancer

Targeted hope for metastatic cancer

by Paul Mayne,University of Western OntarioCancer cell during cell division. Credit: National Institutes of HealthA cancer diagnosis is tough enough to hear, but a diagnosis that cancer has spre
Oncology April 01,2024
Expert panel highlights patient choice for prostate cancer screen (Update)

Expert panel highlights patient choice for prostate cancer screen (Update)

by Dennis Thompson, Healthday ReporterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0(HealthDay)—More men could receiv
Oncology April 01,2024
Expert panel highlights patient choice for prostate cancer screen (Update)

Expert panel highlights patient choice for prostate cancer screen (Update)

by Dennis Thompson, Healthday ReporterMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0(HealthDay)—More men could receiv
Oncology April 01,2024
Metastasizing cancer cells modify bone remodeling with small RNA secretion

Metastasizing cancer cells modify bone remodeling with small RNA secretion

by Tokyo Medical and Dental UniversityIn the bone metastatic microenvironment, the crosstalk between metastasized cancer cells and the surrounding bone cells is critical for the formation of the osteo
Oncology April 01,2024
Metastasizing cancer cells modify bone remodeling with small RNA secretion

Metastasizing cancer cells modify bone remodeling with small RNA secretion

by Tokyo Medical and Dental UniversityIn the bone metastatic microenvironment, the crosstalk between metastasized cancer cells and the surrounding bone cells is critical for the formation of the osteo
Oncology April 01,2024
A new therapeutic target for metastatic and resistant prostate cancers

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D
Oncology April 01,2024
A new therapeutic target for metastatic and resistant prostate cancers

A new therapeutic target for metastatic and resistant prostate cancers

by IDIBELL-Bellvitge Biomedical Research InstituteÁlvaro Aytés & Katia Ruggero. Credit: IDIBELLProstate Cancer researchers from the Bellvitge Biomedical Research Institute (IDIBELL), led by D
Oncology April 01,2024
Expert discusses the deeper complexities of cancer

Expert discusses the deeper complexities of cancer

by University of MichiganCredit: CC0 Public DomainGeeta Mehta studies cancer not simply as masses of cells but as structured organs with multiple cell types that communicate with each other and i
Oncology April 01,2024
Expert discusses the deeper complexities of cancer

Expert discusses the deeper complexities of cancer

by University of MichiganCredit: CC0 Public DomainGeeta Mehta studies cancer not simply as masses of cells but as structured organs with multiple cell types that communicate with each other and i
Oncology April 01,2024
Expert discusses the impact and potential of cancer prevention

Expert discusses the impact and potential of cancer prevention

by Anne Trafton,Massachusetts Institute of TechnologyGreat progress has been made in reducing the cancer death toll through better prevention and screening, according to a new article by MIT Pro
Oncology April 01,2024
Expert discusses the impact and potential of cancer prevention

Expert discusses the impact and potential of cancer prevention

by Anne Trafton,Massachusetts Institute of TechnologyGreat progress has been made in reducing the cancer death toll through better prevention and screening, according to a new article by MIT Pro
Oncology April 01,2024
Metastatic cancer gorges on fructose in the liver

Metastatic cancer gorges on fructose in the liver

by Duke UniversityCredit: CC0 Public DomainBiomedical engineers at Duke University have demonstrated that metastatic cancer cells can reprogram their metabolism to thrive in new organs. Specifica
Oncology April 01,2024
Metastatic cancer gorges on fructose in the liver

Metastatic cancer gorges on fructose in the liver

by Duke UniversityCredit: CC0 Public DomainBiomedical engineers at Duke University have demonstrated that metastatic cancer cells can reprogram their metabolism to thrive in new organs. Specifica
Oncology April 01,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com